AstraZeneca Pharma India Q2 Profit Falls 27%
The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
You May Like To Read
MORE NEWS
Ericsson announces partnership with VVDN for antenna manufacturing in India, aiming to...
Andhra Pradesh is building India's first quantum computing village, featuring advanced...
Crisil Ratings says the 12% safeguard duty on steel imports will protect Indian...
India and the US are negotiating a trade pact aiming to double bilateral trade to USD...
CCI approves Kandhari Global Beverages's acquisition of Coca-Cola's bottling plant in...
The Reserve Bank of India (RBI) has cancelled the licence of Ajantha Urban Co-operative...
Zupee, a real money gaming firm, reports its first annual profit of Rs 146 crore in...
Boeing names Stacie Sire as Vice President and Managing Director of its India...
Mahindra Finance reported a 9% decline in Q4 profit to Rs 563 crore, impacted by rising...
The Competition Commission of India (CCI) has approved Bharat Forge's acquisition of...